Literature DB >> 15383465

Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo.

Kristen M Kerksiek1, Florence Niedergang, Philippe Chavrier, Dirk H Busch, Thomas Brocker.   

Abstract

To better understand the influence of cytoskeletal regulation on dendritic cell (DC) function in vivo, the Rho guanosine triphosphatase (GTPase) Rac1 was selectively inhibited in DCs in transgenic (Tg) mice. Although transgene expression did not interfere with the migratory capacities of DC in vivo, a decreased uptake of fluorescent probes was observed. Interestingly, the absence of full Rac1 function most strongly affected the development and function of CD8+ DCs. Apoptotic cell uptake was severely reduced in Tg mice, impairing subsequent DC-mediated cross-presentation and priming of bacteria-specific T-cell responses. These findings highlight a special role for Rac1 in the capacity of CD8+ DCs to endocytose apoptotic cells and prime T cells via cross-presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383465     DOI: 10.1182/blood-2004-05-1891

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.

Authors:  Petra Schnorrer; Georg M N Behrens; Nicholas S Wilson; Joanne L Pooley; Christopher M Smith; Dima El-Sukkari; Gayle Davey; Fiona Kupresanin; Ming Li; Eugene Maraskovsky; Gabrielle T Belz; Francis R Carbone; Ken Shortman; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

2.  The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.

Authors:  O T Bühler; C A Wiedig; Y Schmid; G A Grassl; E Bohn; I B Autenrieth
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Mechanisms maintaining peripheral tolerance.

Authors:  Daniel L Mueller
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

4.  Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells.

Authors:  Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Immunother       Date:  2008-06       Impact factor: 4.456

Review 5.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin.

Authors:  Hong Li; Tim Oliver; Wei Jia; You-Wen He
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

7.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

8.  HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.

Authors:  Davor Frleta; Carolyn E Ochoa; Holger B Kramer; Shaukat Ali Khan; Andrea R Stacey; Persephone Borrow; Benedikt M Kessler; Barton F Haynes; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

9.  Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.

Authors:  L M Mitchell; K L Brzoza-Lewis; C J Henry; J M Grayson; M M Westcott; E M Hiltbold
Journal:  Cell Immunol       Date:  2011-03-11       Impact factor: 4.868

10.  Role of the CD8+ dendritic cell subset in transmission of prions.

Authors:  Shneh Sethi; Kristen M Kerksiek; Thomas Brocker; Hans Kretzschmar
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.